|
Who are our partner?Pharmaceutical companies (annual turnover from less than €3M to more than €800M) that want to export their products in new markets.
R&D companies with biotech, phase II or phase III products with limited international and business development capacity.
Development companies that want to have access to the above mentioned companies and to developing markets.
Local and regional companies in developing markets that want to have access to NCE (for their markets) and to new developments. |
|
|
